These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 6319530

  • 1. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
    Aman P, Ehlin-Henriksson B, Klein G.
    J Exp Med; 1984 Jan 01; 159(1):208-20. PubMed ID: 6319530
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S.
    Hokkaido Igaku Zasshi; 1985 Sep 01; 60(5):724-34. PubMed ID: 3000906
    [Abstract] [Full Text] [Related]

  • 3. Restrictions upon Epstein-Barr virus infection of the leukemic cell are demonstrated in patients with hairy cell leukemia.
    Sairenji T, Reisert PS, Spiro RC, Mulder C, Humphreys RE.
    Hematol Oncol; 1983 Sep 01; 1(3):251-62. PubMed ID: 6329936
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E.
    Proc Natl Acad Sci U S A; 1987 May 01; 84(10):3452-6. PubMed ID: 3033649
    [Abstract] [Full Text] [Related]

  • 5. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E.
    J Virol; 1991 Dec 01; 65(12):6826-37. PubMed ID: 1658376
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations.
    Aman P, Gordon J, Lewin N, Nordström M, Ehlin-Henriksson B, Klein G, Carstensson A.
    J Immunol; 1985 Oct 01; 135(4):2362-7. PubMed ID: 2993411
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E, Fawaz LM, Tran P, Ahmad A, Menezes J.
    J Natl Cancer Inst; 2001 Nov 21; 93(22):1724-32. PubMed ID: 11717333
    [Abstract] [Full Text] [Related]

  • 12. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG, Crawford DH.
    Intervirology; 1994 Nov 21; 37(5):236-44. PubMed ID: 7698878
    [Abstract] [Full Text] [Related]

  • 13. Specific allergen-induced Epstein-Barr nuclear antigen-positive B cells from patients with chronic-active Epstein-Barr virus infections.
    Olson GB, Kanaan MN, Kelley LM, Jones JF.
    J Allergy Clin Immunol; 1986 Aug 21; 78(2):315-20. PubMed ID: 3016067
    [Abstract] [Full Text] [Related]

  • 14. Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV).
    Yata J, Desgranges C, Nakagawa T, Favre MC, De-The G.
    Int J Cancer; 1975 Mar 15; 15(3):377-84. PubMed ID: 49325
    [Abstract] [Full Text] [Related]

  • 15. Infection of mouse lymphocytes by Epstein-Barr virus. II. Stimulation of cellular DNA synthesis by EBV in the absence of EBNA induction and cell transformation.
    Gross TG, Volsky DJ.
    Virology; 1984 Feb 15; 133(1):211-5. PubMed ID: 6322431
    [Abstract] [Full Text] [Related]

  • 16. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells.
    Sternås L, Middleton T, Sugden B.
    J Virol; 1990 May 15; 64(5):2407-10. PubMed ID: 2157896
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT, Bluestein HG, Zvaifler NJ.
    J Immunol; 1985 Apr 15; 134(4):2287-93. PubMed ID: 2857749
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB, Spelsberg TC, Pearson GR.
    Intervirology; 1984 Apr 15; 22(4):191-200. PubMed ID: 6096291
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.